Jean‐Jacques Bonnet

745 total citations
31 papers, 657 citations indexed

About

Jean‐Jacques Bonnet is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Jean‐Jacques Bonnet has authored 31 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in Jean‐Jacques Bonnet's work include Neuroscience and Neuropharmacology Research (18 papers), Receptor Mechanisms and Signaling (17 papers) and Neurotransmitter Receptor Influence on Behavior (17 papers). Jean‐Jacques Bonnet is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Receptor Mechanisms and Signaling (17 papers) and Neurotransmitter Receptor Influence on Behavior (17 papers). Jean‐Jacques Bonnet collaborates with scholars based in France, Morocco and Poland. Jean‐Jacques Bonnet's co-authors include Jean Costentin, Abdeslam Chagraoui, Philippe Protais, Jean‐Marie Vaugeois, Youssef Anouar, Arnaud Arabo, Dominique Duterte‐Boucher, Anthony Falluel‐Morel, Guy Lavigne and Dorthe Cartier and has published in prestigious journals such as Brain Research, Methods in enzymology on CD-ROM/Methods in enzymology and Journal of Neurochemistry.

In The Last Decade

Jean‐Jacques Bonnet

31 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Jacques Bonnet France 12 413 333 99 62 58 31 657
Masakatsu Nozaki Japan 13 278 0.7× 330 1.0× 18 0.2× 76 1.2× 18 0.3× 68 666
Agnete Dyssegaard Denmark 15 462 1.1× 230 0.7× 64 0.6× 274 4.4× 59 1.0× 32 912
Dorota Matecka United States 13 580 1.4× 398 1.2× 18 0.2× 83 1.3× 25 0.4× 31 716
Richard Rips France 14 268 0.6× 211 0.6× 20 0.2× 113 1.8× 25 0.4× 62 644
Richard J. Perner United States 15 254 0.6× 213 0.6× 20 0.2× 217 3.5× 84 1.4× 16 724
Senait Ghirmai United States 10 124 0.3× 190 0.6× 55 0.6× 45 0.7× 14 0.2× 14 607
Virginia L. Lucaites United States 19 577 1.4× 491 1.5× 67 0.7× 217 3.5× 14 0.2× 24 997
Kevin Whelan United States 10 269 0.7× 304 0.9× 57 0.6× 115 1.9× 21 0.4× 16 685
Ian M. Mawer United States 11 295 0.7× 422 1.3× 24 0.2× 333 5.4× 16 0.3× 12 771
Sofia Baez Sweden 8 126 0.3× 337 1.0× 43 0.4× 42 0.7× 137 2.4× 10 614

Countries citing papers authored by Jean‐Jacques Bonnet

Since Specialization
Citations

This map shows the geographic impact of Jean‐Jacques Bonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Jacques Bonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Jacques Bonnet more than expected).

Fields of papers citing papers by Jean‐Jacques Bonnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Jacques Bonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Jacques Bonnet. The network helps show where Jean‐Jacques Bonnet may publish in the future.

Co-authorship network of co-authors of Jean‐Jacques Bonnet

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Jacques Bonnet. A scholar is included among the top collaborators of Jean‐Jacques Bonnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Jacques Bonnet. Jean‐Jacques Bonnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boukhzar, Loubna, Dorthe Cartier, Yannick Tanguy, et al.. (2016). Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease. Antioxidants and Redox Signaling. 24(11). 557–574. 92 indexed citations
2.
Arabo, Arnaud, Magalie Bénard, Vincent Roy, et al.. (2015). Selenoprotein T Deficiency Leads to Neurodevelopmental Abnormalities and Hyperactive Behavior in Mice. Molecular Neurobiology. 53(9). 5818–5832. 34 indexed citations
3.
4.
Fichna, Jakub, Katarzyna Gach, Anna Wyrębska, et al.. (2011). Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice. Neuropharmacology. 61(8). 1229–1238. 9 indexed citations
5.
Legros, Hélène, et al.. (2004). Semi‐chronic increase in striatal level of 3,4‐dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones. Journal of Neuroscience Research. 75(3). 429–435. 9 indexed citations
6.
Bonnet, Jean‐Jacques. (2003). Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter. European Journal of Pharmacology. 479(1-3). 199–212. 5 indexed citations
7.
Giros, Bruno, et al.. (2001). Involvement of the NH2 terminal domain of catecholamine transporters in the Na+ and Cl−‐dependence of a [3H]‐dopamine uptake. British Journal of Pharmacology. 133(3). 387–394. 5 indexed citations
8.
Corera, Amadou T., Jean-Claude do-Rego, Jean Costentin, & Jean‐Jacques Bonnet. (2001). Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes. Neuroscience Research. 39(3). 319–325. 6 indexed citations
9.
Corera, Amadou T., et al.. (2000). Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements. Naunyn-Schmiedeberg s Archives of Pharmacology. 362(3). 213–221. 8 indexed citations
10.
Giros, Bruno, et al.. (2000). Structural Domains of Chimeric Dopamine-Noradrenaline Human Transporters Involved in the Na+- and Cl−-Dependence of Dopamine Transport. Molecular Pharmacology. 58(6). 1404–1411. 16 indexed citations
11.
do-Rego, Jean-Claude, H Hüe, Jean Costentin, & Jean‐Jacques Bonnet. (1999). Evidence for the Sequential Formation of Two Complexes Between an Uptake Inhibitor, GBR 12783 [1‐[2‐(Diphenylmethoxy)ethyl]‐4‐(3‐Phenyl‐2‐Propenyl)piperazine], and the Neuronal Transporter of Dopamine. Journal of Neurochemistry. 72(1). 396–404. 9 indexed citations
12.
Corera, Amadou T., Jean‐Claude do Rego, & Jean‐Jacques Bonnet. (1998). [14] Specificity and ion dependence of binding of GBR analogs. Methods in enzymology on CD-ROM/Methods in enzymology. 296. 203–219. 4 indexed citations
13.
Costentin, Jean, et al.. (1996). Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier. European Journal of Pharmacology. 301(1-3). 195–202. 9 indexed citations
14.
Corera, Amadou T., Jean Costentin, & Jean‐Jacques Bonnet. (1996). Effect of low concentrations of K+ and Cl? on the Na+-dependent neuronal uptake of [3H] dopamine. Naunyn-Schmiedeberg s Archives of Pharmacology. 353(6). 610–615. 1 indexed citations
15.
Costentin, Jean, et al.. (1994). Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier. European Journal of Pharmacology. 264(3). 391–398. 35 indexed citations
16.
Vaugeois, Jean‐Marie, Jean‐Jacques Bonnet, Dominique Duterte‐Boucher, & Jean Costentin. (1993). In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion. European Journal of Pharmacology. 230(2). 195–201. 38 indexed citations
17.
Bonnet, Jean‐Jacques, et al.. (1993). Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes. European Journal of Pharmacology Molecular Pharmacology. 247(3). 333–340. 8 indexed citations
18.
Lavigne, Guy, et al.. (1987). High-yield syntheses of sulphido triruthenium carbonyl cluster complexes containing bis(diphenylphosphino)methane. Journal of the Chemical Society Dalton Transactions. 91–91. 23 indexed citations
19.
Bonnet, Jean‐Jacques & Jean Costentin. (1986). GBR 12783, a potent and selective inhibitor of dopamine uptake: Biochemical studies in vivo and ex vivo. European Journal of Pharmacology. 121(2). 199–209. 102 indexed citations
20.
Doyle, Michael J., et al.. (1978). Complexes dinucleaires pontes des metaux d8. Journal of Organometallic Chemistry. 146(3). 293–310. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masakatsu Nozaki Breakdown of academic impact, for papers by Agnete Dyssegaard Breakdown of academic impact, for papers by Dorota Matecka Breakdown of academic impact, for papers by Richard Rips Breakdown of academic impact, for papers by Richard J. Perner Breakdown of academic impact, for papers by Senait Ghirmai Breakdown of academic impact, for papers by Virginia L. Lucaites Breakdown of academic impact, for papers by Kevin Whelan Breakdown of academic impact, for papers by Ian M. Mawer Breakdown of academic impact, for papers by Sofia Baez
Rankless by CCL
2026